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“Our greatest glory is not in never falling, but in rising every time we fall.” 
 Confucius 
  
ABSTRACT 
Background: The HIV epidemic in the Asia-Pacific region is characterised by a number of concentrated, and 
in some geographical areas, growing epidemics, particularly among key populations [men who have sex with 
men (MSM), transgender (TG), female sex workers (FSW), and people who inject drugs (PWID)]. Some 
countries in the region have been particularly successful in reducing the incidence rate, but other countries in 
the region have experienced opposite scenarios. The coverage of antiretroviral treatment (ART) is still low in 
the region, ranging between 6-42%. Key populations in many Asia-Pacific countries also frequently suffer 
from discrimination and marginalisation, and their behaviours, often classified as illegal, further increase their 
already high vulnerability to HIV infection. HIV continues to spread predominantly through sexual 
transmission and can be linked to sexual risk behaviours, such as inconsistent condom use. More than 90% of 
all new HIV infections among young people in the Asia-Pacific region occur among young key populations 
belonging to either the MSM, TG, FSW or PWID group. The aim of this study was to understand HIV trends, 
social structural barriers, risk behaviours and retention in HIV care among key populations in 7 countries of 
the Asia-Pacific region, with a special focus on Nepal.  
 
Methods: This project utilised two main data sources: (a) baseline data from a prospective longitudinal study 
of community access to HIV treatment, care and support services (CAT-S) that involved 59 sites in 7 
countries (Bangladesh, Indonesia, Lao People’s Democratic Republic, Nepal, Pakistan, Philippines, Vietnam). 
Between 1 October 2012 and 31 May 2013, a total of 7 843 people living with HIV (PLHIV) aged 18-50 
years were recruited in CAT-S. (b) Nationwide surveillance survey data collected from key populations 
(PWID, MSM, TG, FSW, male labour migrants) across Nepal for over a decade. A total of 7 505 young (aged 
16-24 years) key populations were recruited using two-stage cluster and respondent driven sampling from 
four epidemic zones over a 12-year period, 2001–2012. 
 
Results: We found a high prevalence  of inconsistent condom use among PLHIV in the seven study countries: 
overall 40%, but varying from 17% in Lao People’s Democratic Republic to 60% in the Philippines, did not 
practice safe sex., This was associated with belonging to a key population (drug users, FSW or a refugee sub-
population), poor HIV-treatment literacy and not receiving ART (Paper I). A high proportion of PLHIV (40-
51%) presented late for HIV care, which delayed linkage to care. However, once PLHIV enrolled in care, 
retention in the various steps of the HIV care cascade including adherence to ART was satisfactory (Paper II). 
Findings based on surveillance survey data suggest that adverse micro-level social structural factors such as 
reduced condom-negotiation skills, economic vulnerability, inadequate social support, and experience of 
abuse, contribute to enhance the risk environment associated with unprotected sex among FSW in Nepal 
(Paper III). Our analyses also indicate that the presence of two or more adverse conditions in the physical, 
social, or economic environment of FSW, interacted to increase the risk of unprotected sex among Nepalese 
FSW (Paper III). However, the trend analysis suggests a sharp and consistent decline in HIV prevalence over 
the past decade in different epidemic zones among young key populations in Nepal, most likely due to a 
parallel increase in safe needle and syringe use and increased condom use (Paper IV).  
 
Conclusions: Non-use of condoms and late presentation for HIV care is still highly prevalent among PLHIV 
in the seven study countries. Different adverse conditions, so-called micro-level social structural factors such 
as physical factors (client refusal to pay after having sex), social factors (poor social support and poor condom 
negotiation skills) and economic level factors (unprotected sex to make more money) levels are associated 
with increased odds of HIV-related risk behaviours among Nepalese FSW. HIV prevalence and risk 
behaviours have declined among young key populations in Nepal, but to maintain this downward trend, the 
focus should be on addressing the burden of negative social structural factors (unprotected sex to boost 
income and poor social support). 
Keywords: Condom use behaviour, HIV infections/ prevention, antiretroviral therapy (ART), HIV care cascade, 
syndemic, key populations, Nepal, Asia-Pacific region 
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1 BACKGROUND  
1.1 THE HIV EPIDEMIC IN THE ASIA-PACIFIC REGION 
The contribution of HIV/AIDS to years of life lost globally has been decreasing over time 
(i.e. ranked fourth in 2005 to seventh in 2015) (1). Similarly, the global burden of HIV/AIDS 
estimated as age-standardised disability-adjusted life years also declined by more than 
40%, from 2005 to 2015 (2). An estimated 36.7 million people were living with HIV 
(PLHIV) globally in 2015, 14% of those live in the Asia-Pacific region (3). Almost all 
countries in the Asia-Pacific region are experiencing concentrated HIV epidemics, defined 
as a HIV prevalence of less than 1% in the general population, but more than 5% in at least 
one key population (4, 5). The identified key populations at highest risk of HIV in the 
region are people who inject drugs (PWID), men who have sex with men (MSM), 
transgender (TG) people and female sex workers (FSW) (4). In this region, the epidemic 
among key populations is especially concentrated in urban cities (Figure 1) (4), with some 
exception in local areas within countries that are experiencing a more generalised spread 
(6). One example of this is a remote province of Papua in Indonesia, with a generalised 
epidemic and a 2.4% HIV prevalence among the general population aged 15-49 years (6, 7). 
Another example is that new HIV infections are rapidly increasing among MSM in the 
Philippines where MSM account for 85% of all new infections acquired through sexual 
transmission, due to a lack of targeted health services for this group in the country (8, 9). In 
2015, Joint United Nations Program on HIV/AIDS (UNAIDS) estimated that 5.1 million 
PLHIV in the region, of which 12% were aged 15-24 years (10). In the same year, an 
estimated 300 000 new HIV infections and 180 000 AIDS-related deaths occurred in the 
region (10). Through partnerships with national ministries of health and international 
collaboration, the countries in the Asia-Pacific region have overall successfully managed to 
reduce the number of new HIV infections by 31% between 2000 and 2014 (4). However, 
this preventive achievement has not been consistent, either between or within countries in 
the region (4). Regarding HIV treatment, all countries in the region are rapidly expanding 
access antiretroviral (ARV) treatment services, but the regional coverage of antiretroviral 
combination therapy (ART) in is lower (41% in 2015) than the global average (46%) (3, 4).  
1.2 THE HIV EPIDEMIC IN THE STUDY COUNTRIES  
Two of the papers included in this thesis focus on seven countries in the Asia-Pacific 
region: Bangladesh, Indonesia, Lao People’s Democratic Republic (PDR), Nepal, Pakistan, 
the Philippines and Vietnam. In November 2010 a concept called Treatment 2.0 (T 2.0) (11) 
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was launched by the WHO and the UNAIDS to promote a simplification of a model of HIV 
care, in order to achieve the ambitious target of reaching 15 million people on ART by the 
year 2015.  T 2.0 identified community mobilisation as one of five key areas (optimising drug 
regimens; advancing point-of-care; reducing cost; adapting health service delivery systems; 
community mobilisation) that help to reach and engage key populations (11). In February 
2010, the gathering of 11 National PLHIV Networks from the Asia-Pacific region in 
Bangkok recognised a necessity to monitor, document and share information related to access 
and barriers to HIV treatment among PLHIV in the region. The Asia Pacific Network of 
People Living with HIV/AIDS (APN+) lead its national networks to establish a platform, the 
so-called ‘Monitoring Treatment Access’, to document, monitor and advocate issues related 
to treatment access for PLHIV in the Asia-Pacific region. This platform initially focused on 
seven countries, namely: Bangladesh, Indonesia, Lao PDR, Nepal, Pakistan, Philippines, and 
Vietnam. One of the co-authors (Sushil Koirala) of Paper I and II has been involved from the 
beginning, in establishing the ‘Monitoring Treatment Access’ platform in the region.  
Table 1 summarises the key indicators related to population, government type and major 
health indicators in the study countries (Table 1). The study countries demonstrate 
substantial diversity in terms of the size of the population (from 7 million in Lao PDR to 
258 million in Indonesia), the type of government (communist vs. parlimantiary republic), 
literacy rate (from 58% in Pakistan to 96% in the Philippines), and mortality outcomes such 
as the mortality rate among mothers and their infants: from 54 maternal deaths in Vietnam 
to 258 maternal deaths in Nepal per 100 000 live births, and from 18 infants deaths in 
Vietnam to 51 infants deaths in Lao PDR per 1 000 live births (Table 1). However, all the 
study countries fall under the lower middle-income country category (i.e. a gross national 
income per capita between $1,026 and $4,035) except Nepal, which is categorised as a low-
income economy (i.e. a gross national income per capita of $1,025 or less) (Table 1). 
Nonetheless, Nepal has been among the most successful countries when it comes to 
tackling the HIV epidemic in the region. 
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Table 1. Study countries population size, government type, income level, and major health indicators in 2015 (12).   
Country Total population 
(in millions) 
Government 
type 
Income level Life expectancy 
(in years) 
Maternal 
mortality rate 
(deaths/100,000 
live births) 
Infant mortality 
rate 
(deaths/1,000 
live births) 
Literacy 
(male/female) 
Bangladesh 156 Parliamentary 
republic 
Lower middle 
income 
73.2 176  32.9  61.5% (65/ 59) 
Lao PDR 7 Communist 
state 
Lower middle 
income 
64.3 197  51.4  80% (87/ 73) 
Indonesia 258 Presidential 
republic 
Lower middle 
income 
72.7 126  23.5  94% (96/ 92) 
Pakistan 201 Federal 
parliamentary 
republic 
Lower middle 
income 
67.7 178  53.9  58% (70/ 46) 
Philippines 100 Presidential 
republic 
Lower middle 
income 
69.2 114  21.9  96% (96/ 97) 
Vietnam 95 Communist 
state 
Lower middle 
income 
73.4 54  17.8  95% (96/ 93) 
Nepal  29 Federal 
parliamentary 
republic 
Low income 70.7 258  28.9  64% (76/ 53) 
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In 2016, six countries (China, India, Indonesia, Myanmar, Thailand, and Vietnam) of the 
Asia-Pacific region accounted for more than 90% of the estimated number of PLHIV in the 
region (3). New HIV infections declined over time in Bangladesh, Lao PDR, Nepal and 
Vietnam (Table 2). Nepal and Vietnam stand out as positive examples is many ways related 
to national response to HIV prevention and treatment. In Nepal, new HIV infections fell by 
87% between 2001 and 2012 (Table 2). However, other study countries experienced an 
opposite scenario, such as an 8-fold increase in HIV incidence in Pakistan, an almost 3-fold 
in Indonesia and more than double the HIV incidence in the Philippines between 2001 and 
2012 (4). Similarly, AIDS-related deaths declined or stabilised in Nepal and Vietnam, both 
with relatively high access to ARV treatment but multiplied in other nations with very poor 
ART coverage such as Indonesia and Pakistan (with a 4 vs 3.5 fold increase in AIDS-deaths 
respectively) (4). The rapid expansion of HIV treatment centres in Nepal increased the 
coverage of ART from 18% to 31% in just three years between 2012 and 2015. Currently, 
there are 67 ART centres across in 59 districts (out of a total of 75 districts) of Nepal. In 
March 2017, the country adopted and began to implement a Test and Treat strategy 
throughout the country, meaning that all who test positive for HIV should be initiated on 
ART immediately, regardless of immune status (measured as CD4 count) (11). Nepal also 
expanded the prevention of mother to child transmission services beyond the birthing centre 
in order to move towards elimination of vertical transmission of HIV from a mother living 
with HIV to her child. Since the inception of the HIV epidemic, Nepal has been unique in 
comparison to other countries regarding the involvement of key populations in the 
formulation of both policy, and the design and implementation of HIV prevention programs 
(13). However, other countries such as the Philippines have only recently started to 
implement targeted intervention among key populations such as MSM and the involvement 
of MSM in service delivery is at the infancy stage (8). Vietnam managed to reduce new HIV 
infections in key populations and stabilise death rates among PLHIV with multiple effective 
responses, such as rapid expansion of HIV testing and counselling services, a targeted ‘Test 
and Treat’ strategy i.e. the initiation of HIV treatment immediately after
HIV diagnosis among PWID (11) and integration of HIV services into primary health care 
(14). In Vietnam, ART services are delivered through 364 HIV outpatient clinics. The 
integration of HIV services into primary health centres at sub-district level has drastically 
reduced the time between CD4 testing and the provision of results from 109 days to same day 
notification which has improved timely linkage to HIV care (14). Vietnam prioritises the 
expansion of such efforts in areas where the burden of HIV is high. Incarcerated PWID who 
are living with HIV also received ART through health services in prison, nearby ART centres 
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or through their family members or friends (15). The ART coverage is also higher in Vietnam 
in comparison to other study countries (Table 2).   
There are a plenty of local and regional differences also within countries, but a common 
feature is the concentration of HIV in key populations across all the study countries. For 
example, the HIV prevalence is very high among key populations in certain areas such as in 
Faisalabad in Pakistan where an estimated 50% of PWID are living with HIV and 15% of TG 
people were living with HIV in the Larkana of Pakistan in 2011 (Figure 1) (16). A similar 
level of burden HIV was observed among PWID in Jakarta (56%), and FSW in Jayawijaya 
(25%) of Indonesia in 2013 (16). However, the prevalence of HIV is lower in Nepal (ranges 
from 5% to 8% among PWID in different areas) in comparison to the other study countries 
(Figure 1). Nepal was the first country in Asia to implement a harm reduction program with a 
focus on needle exchange already from the beginning of the epidemic in 1991 (13). Outreach 
workers from community organisations play a crucial role in implementing the needle 
exchange program in Nepal. Members of community organisations are not only active in the 
implementation of interventions, but also responsible for putting pressure on the government 
and donors to prioritise and implement comprehensive HIV preventions services. The HIV 
prevention and treatment responses are heavily dependent on donor support, which ranges 
from 58% in Indonesia to over 90% of the total cost in Nepal (84% in Bangladesh, 93% in 
Lao PDR, 64% in Pakistan, 60% in the Philippines and 68% in Vietnam) (16). Some study 
countries are experiencing a very low coverage of ART, much lower than in most African 
countries for example, e.g. only 6-9% of PLHIV have access to ART in Pakistan and 
Indonesia (Table 2).  
 
In addition to free ARV treatment, some study countries also provide health insurance 
programs that covers costs for PLHIV who seek general health services. Four countries 
(Indonesia, Vietnam, Philippines and Lao PDR) provide ARV drugs and CD4 cell count 
tests free of charge, and have social protection programs such as the Asuransi Kesehatan 
untuk Keluarga Miskin–Askeskin in Indonesia; the Community-Based Health Insurance in 
Lao PDR; the PhilHealth in Philippines; and the Vietnamese Social Security Social Health 
Insurance Program in Vietnam. These programs provide healthcare and other services i.e. 
monthly cash allowance for daily necessities and common drug provision for PLHIV. 
However, studies conducted in Indonesia, Lao PDR and Vietnam found that PLHIV still 
often experience a catastrophic financial burden while seeking HIV/AIDS-related health 
services that are not covered by social protection programs, such as viral load tests, hospital 
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admission fees or diagnosis and treatment of concurrent diseases (6, 17, 18). Loopholes 
also exist in available social protection programs, for example, Indonesian PLHIV who are 
not yet eligible for ART due to high CD4 cell count, need to pay for HIV care (6). The 
coverage of social protection programs is also limited because of health system barriers, 
such as lengthy administrative processes (to obtain an identification card and certificate of 
poverty), unclear procedures, and lack awareness of available social protection services 
among PLHIV (18-20). Insurance that covers health care among PLHIV does not exist in 
Nepal and Bangladesh. In Pakistan, PLHIV can enrol in a health insurance program, but 
there is no available information about coverage or its impact on accessing health care 
among PLHIV.  
 
Table 2.  Estimated number of PLHIV, ART coverage, new HIV infections and AIDS-related 
deaths in study countries (4, 16) 
Country Estimated 
number of 
PLHIV* 
ART 
coverage*  
Trends in new HIV 
infections** 
Trends in AIDS- 
related deaths** 
Bangladesh 9600 16% < 1100 individuals in total < 1000 individuals 
Lao PDR 11000 36% < 1000 individuals in total < 500 individuals 
Indonesia 690,000 9% Increased > 2.6-fold Increased 4-fold 
Pakistan 100,000 6% Increased 8-fold Increased 3.5-fold 
Philippines  42,000 27% Increased by 100% < 1000 individuals 
Vietnam  260,000 42% Declining  Stable 
Nepal 39000 31% Declined by > 80% < 1500 individuals 
*Until the end of 2015 defined as the number PLHIV currently on ART divided by total estimated PLHIV in 
the country; ** Between 2001-2012.  
1.2.1 Burden of HIV among young key populations  
In HIV literature, young people are defined as individuals aged 10-24 years (21), but my 
studies focused on late adolescence (15-19 years) and young adulthood (20-24 years). Their 
developmental stage (experience of complex physical, psychological, emotional and social 
changes) put them in a unique position, often resulting in increased risk-taking associated 
with an increased risk of HIV infection. These behaviours, both sexual risk-taking and 
experimentation with drugs, are due to multiple factors, varying between individuals but also 
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typical for many young people, such as peer pressure, the curiosity of new things and a 
feeling of being immortal (21, 22). Young people belonging to key populations are even 
more vulnerable to the risk behaviours mentioned above because of social rejection of them 
as a group (such as transgender) and because many of their behaviours are highly stigmatised 
in society. Discrimination and violence in combination with power imbalances in sexual 
relationships, developmental immaturity and alienation from family and friends, makes 
young people even more vulnerable to risk behaviours related to HIV-infection (22). Young 
people aged 15-24 years account for 12.4% of the estimated total PLHIV in the region (10), 
and young key populations constitute more than 90% of all new HIV infections among young 
people in the Asia-Pacific region (23). Different surveys found that most of the key 
populations in the region engage in HIV-related risk behaviours already at a very young age 
(Table 3) and they are therefore at high risk of getting infected with HIV early in life and 
while being more sexually active (4, 24, 25). 
Table 3. Age of initiation of HIV-related risk behaviours among young key populations in the 
selected study countries (24)  
Country Mean age in years of sexual debut Median age at 
initiation of drug use  
Mean age of 
sex work 
initiation 
Bangladesh 16  (PWID), 14 (FSW), 13 (MSM), 13 (TG) - 12 years (FSW) 
Pakistan 22 (FSW) - - 
Philippines 16 (PWID)*, 16 (MSM) 19 years (PWID) - 
Vietnam 18 (MSM) - - 
Indonesia 0-19% of were < 15 (FSW) - - 
Nepal 20% FSW are 10-14, Kathmandu  
19% FSW are 12-14, Pokhara Valley  
9% PWID 20–24 years  
53% PWID 15–19 years 
20 years (Male 
sex worker) 
*Median age 
Previous comprehensive assessments of the HIV prevalence among young people in 
countries experiencing generalised epidemics, primarily in Sub-Saharan Africa, have found 
that the prevalence of HIV has declined or at least stabilised in this group over time (26). 
However, the burden of HIV among young key populations has not been analysed as 
systematically in countries in the Asia-Pacific region that have experienced more 
concentrated epidemics (24). The analysis of trends in HIV prevalence at the national level 
may also mask the differences in the burden of HIV between different geographic areas 
within countries (27, 28). The wide knowledge gap in many countries about the burden of 
HIV among young key populations and their behaviours has also been highlighted in the 
2014 World Health Organization (WHO) report, by the Interagency Working Group on four 
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Young Key Populations (MSM, TG, FSW and PWID) (29). Filling the knowledge gap 
related to the burden of HIV, risk behaviours and the effectiveness of interventions targeting 
young people should be an urgent priority to reduce their vulnerability to HIV in the Asia-
Pacific countries (22, 24, 29).  
1.2.2 Burden of social and structural risk factors among key populations    
Key populations in many countries in the Asia-Pacific region not only experience stigma, 
discrimination based on their behaviours (e.g. anal intercourse, injecting drugs) or 
occupation (sex work), but also suffer from state punitive laws that criminalise their 
behaviours (injecting drug use), (see Table 4 for further details) (23). This double burden 
forces key populations into hiding, making them even more marginalised, and in turn, 
increasing their vulnerability to HIV. Vietnam and Lao PDR have punitive laws that 
penalise sex workers for being involved in sex work or solicitation (Table 4), and these 
countries also have compulsory detention centres for PWID and impose the death penalty 
for drug-related offences (4). Pakistan and Bangladesh criminalise same-sex sexual 
activities (4). Indonesia has mandatory detention centres for PWID and the death penalty 
for drug-related crimes (4). The Philippines does not only have punitive laws against sex 
work and solicitation, but the recent inhumane approach of president-elect Rodrigo Duterte 
in dealing with drug-related issues is not only affecting harm reduction programs 
negatively, such as needle-and-syringe exchange programmes, but has so far also resulted 
in the death of around 7 000 people since the abusive war on drugs started in June 2016 
(30, 31).  
Evidence suggests that sex workers and MSM/TG experience inexplicably high burdens of 
physical and sexual violence that affect their self-efficacy to negotiate condom use (32, 33). 
The situation becomes worse in contexts where sex work is criminalised by penal laws (34, 
35). There are also protective laws and policies against discrimination and violence in many 
of the study countries (34, 36). However, typically for some Asian countries, there is a lack 
of enforcement of law and order that in turn exacerbates the experience of discrimination 
and violence among key populations (34). Violence against sex workers by security 
personnel (police/ military) is frequently reported in Bangladesh, Nepal and the Philippines 
(34). In Indonesia, the Philippines and Vietnam police often harass sex workers when they 
confiscate condoms from them (34). Nepalese law allows police to criminalise the clients, not 
the sex workers, but sex workers were charged with creating a nuisance in a public place 
(34). Some countries in the region allow sex workers to work in specific areas under 
government requirements and the government regulates some system of the sex industry, 
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even in countries where sex work is criminalised. Examples are the affidavit system (a 
document made by public notary specifying that woman is an adult and wants to involve in 
sex work with her will) in Bangladesh and Lokalisasi (a government-registered brothel 
complex) in Indonesia (34). Sex work is criminalised in the Philippines, but the government 
recognises the existence of the sex industry and has a law that requires the compulsory testing 
of sexually transmitted infections (STIs) among the staff of entertainment industries, such as 
massage parlours. The law in Indonesia requires some key populations (sex workers) to 
undergo regular testing of HIV and other STIs, but mandatory and coerced testing is also 
reported from Vietnam (34).    
For example, the constitution of Nepal explicitly highlights the protection of sexual and 
gender minorities from discrimination, violence, and abuse (37). However, the experience 
of violence, social rejection and discrimination by society and service providers (health 
workers) is not at all uncommon among MSM/TG in Nepal (38). Another common 
example of the lack of protective law enforcement, is in relation to FSW. There are no 
specific laws that penalise sex work in Nepal, but different studies still suggest that the 
police frequently harass and detain FSW and TG who are involved in sex work, or who are 
working as peer educators (23, 34, 38, 39).  
Evidence also suggests that the risk behaviours among PWID are influenced by the 
interaction between individual level and structural factors that operate in their environment, 
both at the micro (i.e. immediate space, setting, and groups) and macro level (i.e. broad 
social structural characteristics: physical, social, economic, and policy-related) (40). 
Recently, studies conducted among MSM/TG in the USA and Vietnam found that different 
factors (such as experience of depression, violence, sexual stigma, homelessness, substance 
abuse victimisation related to TG identity and incarceration) act synergistically (so-called 
syndemic effects) to increase the risk of unprotected sex and HIV infection among them 
(41-43). Sex workers not only experience disproportionately high burdens of HIV in 
concentrated epidemics, but they are also more likely to experience violence, rejection and 
economic insecurity (32). However, assessments of the role of such adverse factors that 
work at the different level of environment and its synergistic effects on unprotected sex 
among sex workers are very limited (44).  
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Table 4. Situation of punitive laws related to sex work, drug use and male-male sex in the 
study countries (4)  
Country Acts and behaviours criminalised by national law  
 Male-male 
sex 
Sex work Soliciting for 
sex 
Compulsory 
detention 
centres for 
PWID 
Death 
penalty for 
drug-
related 
offence 
Bangladesh Yes No Yes No Yes 
Lao PDR No Yes Yes Yes Yes 
Indonesia No No No Yes Yes 
Pakistan Yes Yes Yes No Yes 
Philippines  No Yes Yes No No 
Vietnam  No Yes Yes Yes Yes 
Nepal No No Yes No No 
 
1.2.3 Prevalence of unprotected sex among PLHIV and key populations  
Protected sex (condom use) among PLHIV is important because it not only prevents sexual 
transmission of HIV but also prevents transmission of drug-resistant HIV strains or re-
infection with a new more virulent HIV strain (45). Globally, around 46% of all estimated 
PLHIV are unaware of their HIV status (46), and the situation is similar or worse across the 
Asia-Pacific region. For example, in Indonesia and Bangladesh, only 26% and 36% 
respectively, of all estimated PLHIV are aware of their HIV status (16). Sexual transmission 
and non-use or inconsistent use of condoms among MSM/TG and sex workers is the main 
cause of infection in the region (4). In Nepal, 85% of all new HIV infections can be attributed 
to sexual transmission, oral, vaginal or anal intercourse (47). The unsafe work environment of 
sex workers, such as changes of venue for selling sex, and varying policing policies for sex 
workers, undermine their accessibility to condoms.  
Meta-analysis findings suggest that factors such as the HIV positive status of partner, poor 
knowledge of HIV and belief that use of condoms decreases the pleasure for male partners, 
lower the likelihood of condom use among PLHIV (48). Some have argued that the use of 
ART and the fact that more people are becoming aware that ART prevents transmission of 
HIV, “treatment as prevention” (TasP), also increases the risk of unprotected sex among 
PLHIV (49). The TasP concept is based on the evidence that PLHIV who adhere to ART  and 
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have no detectable viral load are at least 96% less likely to transmit the virus to their HIV-
negative partners (50). A meta-analytic review of 25 studies found no association between 
receiving ART and inconsistent condom use (31), but it did show that the risk of unprotected 
sex increased among those PLHIV who believed that receiving ART or having an 
undetectable viral load protects against transmission of the virus (51). However, importantly, 
this meta-analysis did not include more than one study from the Asia-Pacific region 
(Australia) (31). A 2013 UNAIDS assessment of the HIV epidemic in the Asia-Pacific region 
found that the major route of transmission is through unprotected sex, among both the general 
public and key populations  (FSW, MSM, TG and sex workers), while the second most 
common contributor to HIV incidence is unsafe use or sharing of unsterile needles and 
syringes among PWID, especially in certain epidemic zones (Figure 1) (4). The 2015 
UNAIDS estimate suggests that new HIV infections increased by 20% in thirty countries 
globally including, among others, Indonesia, Pakistan and Philippines (52). The identification 
of factors that influence unprotected sexual intercourse versus promote consistent condom 
use among key populations including PLHIV is essential in order to plan and implement 
effective preventive interventions (48). However, these factors have not previously been 
systematically assessed among key populations and PLHIV in the Asia-Pacifica region. 
 16 
 
 
Figure 1. HIV prevalence among people who inject drugs and female sex workers in selected areas and cities in the study countries 
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1.2.4 The importance of retention in HIV care 
The relatively recent evidence of TasP (i.e. the very strong protective effect of ART 
regarding the prevention of HIV transmission from an HIV- positive partner adhering to daily 
ART mentioned above), has given hope that it is possible to end the AIDS epidemic by 2030 
(50). Traditionally, the eligibility for HIV treatment among PLHIV is guided by the CD4 cell 
thresholds. However, the evidence from different studies (HIV Prevention Trials Network 
052 Trial, the Strategic Timing of Antiretroviral Treatment Study) (50, 53) clearly suggest 
that the benefits of early initiation of ART (immediately after diagnosis) is far better in terms 
of both health and prevention benefits of ART, than delaying treatment for any reason. The 
initiation of HIV treatment immediately after diagnosis is called the ‘Test and Treat’ strategy 
(11). 
National strategic plans for the countries of the Asia-Pacific region have aligned with 
UNAIDS’ so-called “fast track strategy” towards achieving the “90-90-90 target” by 2020 
and “95-95-95 target” by 2030 (54). The 90-90-90 target, means that 90% of PLHIV should 
know their HIV status, 90% of PLHIV who know their HIV status should receive HIV 
treatment, and 90% of PLHIV on ART should be virally suppressed i.e. have undetectable 
viral load and thereby be at minimal risk of transmitting HIV as well as of symptomatic HIV 
(54, 55). If the world managed to reach the 95-95-95 target in 2030, it would mean the end 
the AIDS epidemic as a global public health threat. Regarding figures, this would mean that 
the number of new HIV infections would be 89% lower, and the number of AIDS-related 
deaths would be 81% lower compared to 2010 (54). An improved coverage of ART among 
PLHIV would result in a total number of below 97 000 new HIV infections in the Asia-
Pacific region (54). However, if the ART coverage remains at the 2013 level, then new 
infections would be expected to reach 480 000 by 2030 which is even higher than the current 
level of 300 000 new infections in 2015 (54).  
Treatment of HIV is usually assessed by and divided into the following critical steps for 
treatment success, the so-called “HIV care (or treatment) cascade”: proportion of PLHIV 
should know their HIV status, proportion who present in health care on time (i.e. with  a CD4 
at higher level of 350-500 cells/µl or with no AIDS-defining illnesses), proportion linked to 
care on time (for CD4 test and other health-related assessment) and proportion that initiates 
ART if eligible (if test and treat strategy adopted in the country then they should immediately 
start ART) and fully adhere to ART to achieve viral load suppression (54) (Figure 2).  
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To what extent these different steps within the HIV care cascade are reached will heavily 
influence the success or failure of the 90-90-90 targets. Countries in the region assessed the 
achievement of the 90-90-90 targets by combining modeled data with cumulative routine 
program data (47). Estimating the number of PLHIV living in each country requires many 
sources of information for entry into existing HIV models (56), including mapping the 
number of key populations at risk in the country, collecting surveillance data on HIV 
prevalence and risk behaviours among key populations, measuring access to ART and 
coverage of prevention of mother to child transmission service related information and other 
inputs (56). Some of the countries in the region lack such information because valid estimates 
require surveillance survey data of at at least three time points, or because there are no valid 
or updated estimates of the number of key populations in the country, and /or because they 
lack accurate data on AIDS deaths, etc.) (57). This information gap obviously increases the 
uncertainty of estimated numbers in these countries and in the region as a whole. For 
example, Nepal conducted the latest mapping to estimate the number of key populations only 
in 2016 and before that, country was using 2010 mapping data as an input for national HIV 
estimates for over 5 years.   
Similarly, cumulative routine program data also suffers from several limitations, such as 
duplications of cases, aggregate level data since the inception of the epidemic and so on. 
Figure 2 shows the different steps of HIV care cascade among PLHIV in Nepal (Figure 2). 
The first bar represents the estimated number of PLHIV as modelled using the UNAIDS’ 
developed Spectrum/ AIDS epidemic model, while other values were extracted from routine 
national program data of country (56). Current data sources do not, give a completely clear 
picture of various countries’ progress towards the 90-90-90 target due to inherent uncertainty 
limitations of the estimated number of PLHIV and aggregated routine program data as 
mentioned above (58). Hence, the identification of facilitators and barriers for each individual 
step in the HIV care cascade is essential in order to modify and improve existing programs 
and for planning new even more effective interventions.      
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Figure 2. The 2015 HIV care cascade in Nepal (16). *Number of people on ART who received a viral load test in the past year and have viral load <1000 
copies/mL
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1.3 HEALTH SYSTEM RESPONSE TO HIV IN THE STUDY COUNTRIES 
Several achievements have been made in the last two-three decades in the region, related to 
economic and health status such as improved life expectancy, declining fertility, improved 
social capital and increasing income (Table 1) (59). However, such achievements are neither 
consistent between countries nor within countries. A wide variation in the availability of 
opportunities and services by location (nation-wide vs. rural- urban) in many countries of the 
region increases the inequities between populations with regards to health risks, health-
seeking behaviour, accessibility to services and health outcomes. For example, Singapore 
managed to deliver well-resourced medical services within reach of all citizens, whereas 
inequity in access to healthcare between rich and poor, and between urban and rural areas is 
common in Indonesia (59, 60). Studies found that wealthy Indonesians living in urban areas 
were seven times more likely to access health services from both public and private health 
facilities than Indonesians in the poorest income groups (60). The entrenched poverty and 
gender inequality in many countries of the region has also resulted in one-fifth of all deaths 
being due to infectious diseases despite the on-going global transition from communicable to 
non-communicable burdens of disease (59).   
Health systems are comprised of many components, with the primary aim to promote, 
restore, and maintain health. The 2007 WHO framework, so-called ‘Everybody’s business: 
strengthening health systems to improve health outcomes’, identified six building blocks of a 
health system: health service delivery, human resource, health information system, medical 
products and technology, health financing, leadership and governance (59). The central 
concept of that framework is that the health system should be understood in totality, and that 
just focusing on one block will not be sufficient to achieve high-quality health care.  
Some groups (women and children, especially girls) within the region are more 
disadvantaged than others both in terms economic and health status (59). The poor status of 
women in different aspects of life such as literacy level, nutritional status, access to health 
care and decision-making power regarding contraceptive use and family size, results in 
persistently high maternal and child mortality rates in some countries of the region (Table 1). 
Male child preference has led to selective abortion of female fetuses, because of the belief 
that a son is the better provider in patriarchal societies, regarding both religious and economic 
aspects (59, 61). Thus, in many patriarchal societies, female children are still being deprived 
of education, which ultimately affects both women’s employment opportunities and their 
health status (61). In 2015, all study countries exhibited low Gender Inequality Index 
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rankings (62). The Gender Inequality Index measures gender inequalities in three aspects of 
human development—reproductive health (measured by maternal mortality ratio and 
adolescent birth rates), empowerment (measured by proportion of parliamentary seats 
occupied by females and the proportion of adults with at least some secondary education) and 
economic status, (female/male labour market participation rates). The lower down on the list 
of 159 ranked countries, the worse the inequality and although rankings vary significantly 
between the study countries, from 71 in Vietnam to 130 in Pakistan, 119 in Bangladesh and 
106 in Nepal none of them does well(62).  
The guiding principles behind all the health systems in the Asia-Pacific region come from the 
1978 Alma-Ata declaration on Primary Health Care (63). In the Declaration of Alma-Ata, 
primary health care was defined as: “…….essential health care on practical, scientifically 
sound and socially acceptable methods, and technology made universally accessible to 
individuals and families in the community through their full participation, and at a cost that 
the community or country could afford to maintain at every stage of their development, in the 
spirit of self-reliance and self-determination. (63).”  
In reality, the health system is fragmented in many countries of the region resulting in 
ineffective delivery of health services. Poor access and low quality of health services result in 
low uptake and coverage even of basic health services in many Asian-Pacific countries. The 
reasons for poor access and low quality of health services are summarised in Figure 3 (Figure 
3). An attempt has been made by governments to improve health service delivery in 
partnership with the private sector, but the public-private partnership is not regulated by 
effective laws, in turn resulting in the region having the world’s highest reliance on out-of-
pocket expenditure to finance health care system (59). The governments in the region 
contribute the larger portion of the health workforce, but the distribution of health personnel 
is skewed and mainly concentrated in the major cities. In many low-income countries of the 
region, the current health management information systems do not generate valid and useful 
indicators at the disaggregated level required in order to enable decision-makers to evaluate 
existing efforts and to support an evidence-informed response. Thus, the available health 
system information is rarely used in designing policy and implementing interventions. The 
laboratory services are often under-resourced and fragmented. In Nepal for example, only one 
viral load-testing machine for ARV treatment assessment is available outside of the capital 
city. Government spending on health services is highly inadequate, resulting in a challenge to 
provide even basic health services, and HIV-related programs are therefore largely dependent 
on and supported by international donors (59). 
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Figure 3. Challenges unique to six building blocks of the health system in the Asia-Pacific region (59, 60).  
Medical products and technologies 
Bangladesh, Pakistan, Nepal: Inadequate and unavailable in rural areas 
Health workforce 
Bangladesh, Pakistan, Nepal: Shortage of qualified health workers (HW), HW often unwilling to 
work in rural areas, frequent transfer of HW 
Health information system 
Bangladesh, Pakistan, Nepal: Lack of disaggregated information, data not available on time to 
guide response 
Health service delivery 
Indonesia, Nepal: Poor physical access to health clinics where quality services exist 
Health financing  
Bangladesh, Nepal, Pakistan, Indonesia, Vietnam: Lack of funding for basic health services, 
public funding primarily allocated for tertiary care/urban hospitals, some vertical programs 
(disease specific) are heavily dependent on donor funding H
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Improved 
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Leadership and governance  
Bangladesh, Pakistan, Nepal: Clear plans lacking to depute HW in rural areas, poor regulation 
of health service delivery through public-private partnership, few plans to protect poor and 
vulnerable from catastrophic economic loss when seeking health care  
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1.3.1 Interventions targeting key populations in the region  
Behavioural interventions targeting key populations often include peer-driven education 
interventions and HIV testing and counselling services (HTC), both of which are widely 
implemented in both formal and informal settings in the Asia-Pacific region (64). In peer 
education interventions, individuals (peer educators) are selected from key populations and 
trained to increase their awareness on HIV/AIDS and other STIs and to encourage 
behavioural change among other key population members (65). The peer interventions are 
usually implemented through peer educators in informal settings (public meeting places such 
as parks, bus stops, temple areas and injecting hot spots such as under bridges and jungle 
areas) or through drop-in centres in more formal settings such as outpatient clinics. Peer 
educators also usually distribute necessary supplies such as condoms, lubricants and syringes, 
often paid for by the government, or by donors via community organisations lead by various 
key populations. Peer educators often also receive salary support from such community 
organisations.  
The second intervention, HTC, consists of pre-test counselling, post-test counselling and 
informing clients about their HIV status following the HIV test. In pre-test and post-test 
counselling, the counsellors assess the clients’ risk behaviour, prepare clients for their HIV 
test result and teach coping and risk reduction strategies, as well as recommend further care 
and support if necessary. Both interventions are effective in influencing different intermediate 
outcomes such as increasing knowledge of HIV risk reduction strategies, beliefs, attitudes 
and behaviours, which in turn is thought to promote clients to take up safer and healthier 
behaviours that affect health outcomes (HIV infection) in the long run (64, 66). 
Seventeen countries of the Asia-Pacific region, with an estimated 3.15 million PWID, make 
up a 1 in 4 population of PWID out of the global total (67). The majority of the governments 
in the region understand the importance of harm reduction packages to prevent the sharing of 
injecting equipment, rates of drug use and HIV infections among PWID (35, 68).  However, 
until 2014, only 17 countries in Asia implemented needle and syringe exchange programs, 
and only 15 countries implemented opioid substitution therapy (67), although 3-5 million are 
estimated to be PWID in the whole region, 16% of them living with HIV (69). The evidence, 
therefore, shows that the adoption and implementation of harm reduction is slow and 
challenging in many Asian countries (68). Due to poor coverage of harm reduction services 
(for example, the number of syringes per person injecting drugs distributed in one year ranges 
from only 10 in Indonesia to 214 in Bangladesh) and other existing barriers, such as policy 
inconsistency between different ministries, negative opinions with regards to harm reduction 
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among health care managers and medical staff, negative attitudes towards PWID in general, 
lack of knowledge about addiction treatment etc., all means the sharing of unsafe needle and 
syringes among PWID remains a big problem in the region (35, 69, 70). So far, only four 
countries of the Asia-Pacific region are able to reach the recommended standard coverage of 
more than 200 needles/syringes provided per PWID per year (67). Most of the countries in 
the region adopt a blanket approach in implementing interventions without considering the 
needs and demands of different age groups, often because the needs and demands are 
insufficiently known.   
Existing harm reduction programs mainly focus on needle and syringe exchange programs 
and drug addiction treatment, primarily opioid substitution therapy i.e. oral methadone and 
buprenorphine distribution as replacement drugs to opioid/heroin dependency (71) These 
programs are largely funded by foreign donors (as much 81% of the total harm reduction 
activities in the region) such as the Global Fund to Fight AIDS, Tuberculosis and Malaria and 
other bilateral partners (46). Also, many programs lag behind the rapidly changing drug scene 
in the region, where the use of methamphetamine is increasing over the use of heroin, but the 
harm reduction programs focus solely on injecting drug use among PWID (35). Despite the 
strong international evidence-base in favor of harm reduction (69), for example, the 
Vietnamese government required long efforts of piloting and more evidence generation (46). 
As of June 2015, there were 32 000 clients receiving methadone maintenance therapy 
through 162 clinics in 44 provinces (46), estimated to make up only 12% of the total PWID 
population in Vietnam (72). Nepal is also implementing opioid substitution therapy through 
14 sites in eight districts, but the retention rate is dismal, at less than 3% (47). Different 
factors may contribute to poor retention in opioid substitution therapy among PWID Nepal, 
such as no takeaway doses being provided meaning that the patient needs to go to the clinic 
to pick up his or her dose every day. Pakistan is also finally implementing a needle exchange 
program, but with limited coverage and poor access to opioid substitution therapy for PWID, 
it is still in its infancy (73).  
 
1.4 KEY POPULATION SURVEILLANCE METHODS FOR THIS THESIS 
Random sampling of key populations was not feasible in this study because of the 
unavailability of a sampling frame. Key populations are hidden in society and difficult to 
recruit, mainly due to the stigma and discrimination associated with their behaviours (74). A 
unique sampling technique, the so-called respondent driven sampling (RDS) technique has 
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been designed to recruit hard to reach populations without a sampling frame. In the Asia-
Pacific region RDS has therefore been used to recruit key populations (75, 76), oftentimes by 
using networks of study participants for recruitment with the help of their peers who practice 
the same behaviour. The recruitment process is controlled in a number of ways, such as a 
fixed number of peers that can be recruited by one participant. The strength of RDS is that it 
manages to produce selection probabilities of study participants, which enhances its 
credibility as a probability sampling technique. The selection probability is based on the 
personal network size of study participants, which is measured by assessing the number of 
people in the network of study participants who also fulfil the inclusion criteria of the study. 
Evidence suggests that RDS produces statistically proven unbiased population estimates 
when all the criteria are fulfilled (77, 78). One disadvantage of this sampling technique is that 
RDS sometimes only is able to reach a subset of the study population in some contexts (76).  
or the estimate is biased if the study participants only recruit those peers who have 
characteristics related to the outcome of interest, such as referring only MSM with known 
HIV positive status (78).     
 
1.5 RATIONALE FOR THIS THESIS 
The well-established evidence regarding the effectiveness of ART both in reducing secondary 
HIV transmission, so-called ‘Treatment as prevention’, as well as its strong health benefits 
has given hope to ending AIDS as a public health threat. However, to achieve this ambitious 
target, the risk behaviours that contribute to HIV transmission need to be addressed, and the 
achievement of a high level of retention in HIV care among PLHIV is crucial. The 
identification of facilitators and barriers of PLHIV in different steps of the HIV care cascade 
is essential in order to modify existing interventions or to plan a new ones. At present, there is 
a knowledge gap in the study countries, in understanding the factors affecting for example 
inconsistent condom use and retention in HIV care among PLHIV 
Evidence from high-income countries suggests that the risk behaviours among key 
populations are influenced by the interaction between different factors that operate on the 
micro versus macro levels of their environment. Those factors also act synergistically (so-
called syndemic effects) to increase the risk of unprotected sex and HIV infection in these 
groups. However, such associations have not earlier been assessed among FSW in low-
income countries despite the fact that experience of violence, social rejection and economic 
insecurity is very common among them. This thesis aimed to contribute to filling the 
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knowledge gaps related to factors affecting inconsistent condom use and retention in HIV 
care among PLHIV in 7 countries, including the burden of HIV prevalence, risk behaviours 
among young key populations and synergistic effects of structural factors among FSW in 
Nepal.  
Despite the significant proporiton of key populations in the Asia-Pacific region engaging in 
risk behaviours at a young age, the burden of HIV among young key populations has not 
been systematically analysed in the Asia-Pacific region, and Nepal is not an exception. The 
analysis of trends in HIV prevalence at the national level may also mask the differences in the 
burden of HIV between different geographic areas within countries. Filling the knowledge 
gap related to the burden of HIV, risk behaviours and the effectiveness of interventions 
targeting young key populations by local epidemic zones is an urgent priority to reduce their 
vulnerability to HIV.  
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2 AIM AND OBJECTIVES 
 
General Aim 
To assess the HIV trends, risk behaviours, social structural barriers and retention in HIV care 
among key populations in seven countries (Bangladesh, Indonesia, Lao PDR, Nepal, 
Pakistan, Philippines and Vietnam) of the Asia-Pacific region and in Nepal in particular. 
 
Specific Objectives  
1. To examine the prevalence of inconsistent condom use and associated risk factors among 
people living with HIV in seven countries located in the Asia-Pacific region (Paper I). 
 
2. To assess factors affecting retention in HIV care at the most crucial steps in the HIV  
treatment cascade for people living with HIV in seven countries in the Asia-Pacific region 
(Paper II). 
 
3. To assess the prevalence of HIV and the syndemic effects of micro-level social structural 
factors of unprotected sex among female sex workers in Nepal (Paper III).  
 
4. To determine any change in HIV prevalence and risk behaviours, socio-demographics 
and comprehensive HIV/AIDS knowledge over the last decade (2001-2012) among 
young key populations aged 16-24 years in Nepal (Paper IV).  
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2.1 CONCEPTUAL FRAMEWORK FOR STUDY  
 
Figure 4 shows how availability, accessibility and utilisation of different interventions influences risk behaviours and HIV incidence. The performance of 
the health system also affects the retention of PLHIV in HIV care, in turn ultimately affecting the HIV burden (HIV prevalence) and health status 
(morbidity and mortality) of PLHIV. Health system responsiveness, either in a positive or negative way, is a yardstick of its performance. For example, 
how health systems meet the needs of people’s expectations is one of the measures of its performance. Individual level and structural factors act 
synergistically (so called syndemic effects: the idea that two or more adverse conditions interact interdependently to heighten the burden of disease in a 
population) to influence the outcome and impact either in the positive or negative way.  
 
Figure 4. Conceptual framework for factors affecting risk behaviours, HIV prevalence and retention in care among key populations and PLHIV. Adapted 
from Funnell (79); Rhodes (40); Singer (80) 
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Figure 5. Summary of objectives, study population, study design, study area and data collection methods   
 
Objectives 
1. To assess the 
prevalence of 
inconsistent condom 
use and its 
correlates 
2. To assess the 
factors affecting 
participation in the 
HIV care cascade 
3. To assess the 
syndemic effects of 
social structural 
factors of unprotected 
sex  
1.  
4. To assess the 
changes in HIV 
prevalence and risk 
behaviours 
Study population 
Men, women and MSM and TG 18-50 years 
of age with a self-reported  HIV diagnosis ≥ 
3 months before the interview 
Women age 16 years and above reporting 
having been paid in cash or kind for sex 
with a male within the last 6 months 
Young key population age 16-24 years: 
PWID (men injecting drugs for at least three 
months); MSM/TG (men having had anal 
sex with another man in the last 12 
months); FSW (same as paper III; male 
labour migrants (men at least 18 years of 
age having worked in India for at least three 
months and returned to Nepal within three 
years prior to the date of survey) 
 
Study area, sample size, 
designs, data collection 
methods and period 
Bangladesh, Indonesia, Lao PDR, 
Nepal, Pakistan, Philippines, 
Vietnam; questionnaire-based 
interviews (n=7843 PLHIV); 
October 2012 and May 2013 
22 districts of Nepal; rapid HIV 
testing and questionnaire-based 
interviews (n=610 FSW); 
September-November 2012 
Four epidemic zones of Nepal; 
rapid HIV testing and questionnaire-
based interviews (n=7505 young 
key populations); 2001-2012 
III 
IV 
Paper 
I and II 
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3 MATERIALS AND METHODS 
3.1 THEORETICAL FRAMEWORK TO STUDY RETENTION IN HIV CARE AND 
SYNDEMIC EFFECTS OF STRUCTURAL FACTORS 
Barriers and facilitators of retention in HIV care between HIV testing and ART initiation 
were assessed based on a theoretical framework of access to health care developed by 
Anderson (81). Based on this theory, we further identified different populations and health 
system factors that could influence access to care and retention in care for PLHIV (the HIV 
care cascade) (50). Population level determinants have earlier been categorised as 
predisposing, enabling and need determinants (81). Predisposing individual level factors 
include socio-demographics (age, sex, marital status, family size), social factors (education, 
occupation, and ethnicity) and beliefs (knowledge of health and health services) (81). 
Enabling factors facilitate or hinder individuals’ access to and participation in care such as 
insurance, income and cost of health care (81). Need factors were categorised as the 
perceived need of care defined as an individual’s perception of one’s health status and the 
need for care, and evaluated need where health workers more objective quantification of an 
individual’s need for care (81). Health system factors involve resources (human resources, 
availability of medical equipment, infrastructure) and organisational factors (interoperability 
of resources and system in the delivery of care) (81). Based on Andersons’ theory of access 
to health care, Paper II defined population and health system factors that facilitate or hinder 
PLHIV from HIV testing, linkage to HIV care, engagement in care and ART initiation.  
A synergistic effect of micro-level social structural factors on unprotected sex among FSW 
was assessed based on the ‘risk environment’ and ‘syndemic theory’ proposed by Rhodes 
(40) and Singer (80) respectively. A risk environment framework suggests that the 
behaviours of key populations are determined by the interactions between individual and 
social structural factors (i.e. physical, social, economic, and policy-related) that operate at the 
micro (immediate setting) and macro level (broad social structural characteristics). Social 
structural factors are defined as barriers and facilitators at different levels such as economic, 
social and policy-related that influence the ability of an individual’s HIV prevention 
behaviour (82). Syndemic theory, a recently gained momentum for a new pathway for global 
health research (83), studies the synergistic effects of two or more epidemics or adverse 
conditions that increase the burden of disease in a population (80). Based on the risk 
environment concept developed by Tim Rhodes and syndemic theory developed by Meril 
Singer, Paper III assesses the syndemic effects of micro-level structural factors that operate at 
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a physical, social and economic level to increase the likelihood of unprotected sex among 
FSW in Nepal (Paper III).   
3.2 STUDY DESIGN 
This research project utilised two main data sources: 
For Paper I and II:  For paper I and II, baseline data from a prospective longitudinal study 
of community access to HIV treatment, care and support services (CAT-S), which used a 
community-based participatory research (CBPR) approach (84) that involved 59 sites in 7 
countries (Bangladesh, Indonesia, Lao PDR, Nepal, Pakistan, Philippines, Vietnam) between 
October 2012 and May 2013 in the Asia-Pacific region (Figure 6). CAT-S is one of the key 
pillars of Monitoring Access to Treatment in Asia (MATA) -a tool to document, monitor, and 
advocate issues related to access to treatment, care and support for PLHIV over the long term 
(85). The CAT-S collected data through face-to-face interviews, regarding wide range of 
variables (sociodemographics, HIV diagnosis and healthcare, health seeking 
behaviour/access to general health care and associated cost, access to social support, stigma 
and discrimination, general health and HIV risk behaviours, access to reproductive health 
and family planning service, tuberculosis and hepatitis C virus infection, HIV treatment 
literacy, access to information technology, ART initiation and adherence, side effects of 
ART and relationship with health workers). The CAT-S study was funded by the Global 
Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) Round 10 regional grants.  
 
For Paper III and IV: A National level surveillance survey, called the integrated biological 
and behavioural surveillance (IBBS) survey data was used to answer the objectives of Papers 
III and IV. The IBBS survey is a serial cross-sectional survey that has collected data among 
key populations (PWID, MSM/TG, FSW, male labour migrants) across Nepal since 1999. 
IBBS surveys have since then been conducted at regular intervals (every 2-3 years) among 
key populations from 16 years of age and above in different HIV epidemic zones of Nepal 
(please see below and also Figure 7).  
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Figure 6. Sample sizes and sites in the study countries of Papers I and II. 
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3.3 STUDY SETTING 
 
Details of the study countries, number of study sites and sample sizes related to Papers I and 
II are shown on the map in Figure 6 (Figure 6). Details of IBBS survey by epidemic zones are 
shown on the map in Figure 7 (Figure 7). Nepal is divided into different epidemic zones 
based on the burden of HIV, risk behaviours and mobility patterns in the area. The HIV 
epidemic in some Nepalese regions is driven by unsafe needle sharing and unsafe anal sexual 
intercourse, whereas it in the other local regions is driven more by labour migrants being 
clients of sex workers when working abroad (86). The IBBS survey was conducted in such 
areas targeting specific key populations in each area.  
3.4 STUDY POPULATION, DATA MANAGEMENT, AND DATA ANALYSIS  
 
For Papers I and II, individuals (men, women and MSM/TG) aged 18-50 years, who self-
reported to having been diagnosed with HIV at least three months before the date of 
interview, were recruited. We used both targeted sampling and facility-based sampling. A 
modified targeted snowball sampling technique (77) that helped us understand the existence 
of different subgroups in a particular setting, was used to recruit study participants from 
identified geographical areas. Snowball sampling is effective for recruiting hidden 
populations, but increases the risk of oversampling easily available study participants and 
may also be too much influenced by the characteristics of the initial study recruits also 
called ‘seeds’ (77). We therefore used modified targeted snowball sampling, assumed to be 
more effective and valid for recruiting hidden marginalised populations. We call it 
modified snowball sampling because we followed two key steps before identifying ‘seeds’ 
that could facilitate the enrolment of study participants. In the first step, we identified areas 
within each of the seven countries where we could enrol study participants by using 
national and local networks of PLHIV. Most key populations are involved in smaller or 
larger networks of people who have similar behaviours and characteristics. Contact persons 
for the various networks also helped us to identify different key populations (sex workers, 
MSM and transgender and PWID living with HIV) in each study area. In the second step, 
we also performed a review of the secondary literature to estimate a possible number of 
PLHIV in the country study areas. Thereafter, we selected ‘seeds’ in each of these study 
areas to enroll study participants. Facility-based sampling techniques were used to recruit 
study participants from different institutions (health centers/hospitals, self-help groups, 
outreach/drop-in centers and different treatment, rehabilitation centers).
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Figure 7. IBBS survey population by epidemic zone in Nepal (Papers III and IV).  
KTM valley: Kathmandu valley; MSM/TG: Men who have sex with men/transgender; PWID: people who inject drugs; FSW: Female sex workers.
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An Electronic Data Capture system (iDataFax) was used to submit data to the Center of 
Excellence for Biomedical and Public Health Informatics (BIOPHICS) located at Mahidol 
University. Upon receipt of the data, a data officer at the Asia Pacific Network of People 
Living with HIV/AIDS (APN+) was responsible for a visual review of the data for missing 
values and query other inconsistencies in country specific data.  
All the data analysed using the RDS Analyst version 0.42 and STATA version13.1 software 
(Stata Corporation, College Station, TX). 
For Paper I, various independent variables were analysed to answer the objectives of Paper I. 
Age, sex, education, occupation, income, living area, nongovernmental organization or 
community-based organization membership, and belonging to a key population (MSM, TG, 
PWID, refugee, migrant workers or sex workers) at high risk of becoming infected with HIV 
were recorded as demographic characteristics. Factors having an established or theoretical 
association with condom use behavior were taken into consideration: social support, stigma 
and discrimination, general and reproductive health, HIV diagnosis, and HIV treatment and 
related literacy.  
Measures on stigma and discrimination included physical assault and housing instability in 
the past twelve months, amongst others. To assess general and reproductive health, self-rated 
health, illicit drug use (“Have you ever used any illicit drugs?”; the response was categorized 
as “never used drugs” vs. “current drug user” vs. “former drug user”), and alcohol 
consumption (categorized as “never drinkers” vs. “former drinkers” vs. “current drinkers”) 
were recorded. Furthermore, participants were asked if they had children and/or if they had a 
desire to have children in the future. Time since the HIV diagnosis, in years and place of the 
HIV diagnosis, were recorded as measures related to the HIV diagnosis. Measures on HIV 
treatment included current enrollment in ART and related so called treatment literacy, which 
was assessed by asking participants to rate HIV-related statements (e.g. “Condoms are not 
needed if both sexual partners are HIV-positive.”) as either true or false. Participants who had 
had sex with a regular partner in the past six months were further asked to indicate their 
partner’s HIV status, whether they had ever disclosed their HIV status to their partner, and 
whether they had sexual intercourse with someone other than their regular partner in the past 
six months. Condom availability (“Can you get a condom when you need it?”) was recorded 
and categorised into “always or mostly”, “sometimes”, and “never”. 
For Paper I, logistic regression was used to examine the association between independent 
variables and the outcome defined as inconsistent condom use. Svy: logistic of STATA 
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software was used to fit the statistical model, taking into account the complex survey data (in 
our case multilevel cluster design with seven countries and 59 sites). Logistic regression 
analysis was done to assess factors associated with condom use behaviour with a regular 
partner and with a casual partner. The variance inflation factors (VIF) indicated no 
problematic multi-collinearity (all VIF-values ≤ 1.51). All statistical tests were based on a 
significance level of a p-value ≤ 0.05 and confidence intervals (CI) were set at 95% 
confidence level. 
The outcome variables of Paper II were HIV testing, linkage to care, engagement in care, 
initiation of ART and ART adherence. HIV testing was assessed as a late presentation for 
HIV care (yes vs. no), which was defined as PLHIV presenting with CD4 cell count <200 
cells/μl at the time of the first diagnosis of their HIV infection. Linkage to care was 
dichotomized as ‘timely meeting with health workers for HIV care’ (attending an 
appointment within 30 days of an HIV diagnosis) and timely CD4 testing (having had one or 
more documented CD4 tests within three months of an HIV diagnosis). Engaged in care was 
assessed as PLHIV who had at least one HIV medical care visit in the last 12 months. 
Initiation of ART was assessed as PLHIV who were eligible to take ART and also actually 
did receive ART. ART adherence over the past month was assessed by visual analog scale 
(VAS): “We would like to get your best guess about how much of your anti-HIV medication 
you have managed to take in the last month?” and asking the interviewee to estimate their 
adherence proportion (visual analog scale from 0% to 100% in 10% intervals; 0% meaning 
that the respondent has not taken any medication, and 100% meaning that s/he has taken 
every single dose) of their prescribed ART in the last month. ART adherence was later 
dichotomized into ≤90%: poor vs. >90%: good adherence.  
For Paper II, statistically significant associations between independent variables (population 
and health system factors) and the retention in HIV care between HIV testing and ART 
initiation were computed using a generalised structural equation model (GSEM), using the 
‘Bernoulli-Logit function’. GSEM also allowed us to address the complex sample survey 
design in the analysis. Svy: gsem of STATA was used to fit the statistical model for complex 
survey data. 
For Paper II, the different independent variables that are related to population level and health 
system factors are analysed as independent variables (Table 5).  
For Paper III and IV,  the inclusion criteria for IBBS survey participants were defined as 
follows: PWID (men at least 16 years of age and self-reported as injecting drugs for at least 
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three months); MSM/TG (men at least 16 years of age and self-reported having had anal sex 
with another man in the last 12 months); FSW (women aged 16 years or above reporting 
having been paid in cash or kind for sex with a male within the last 6 months); and male labor 
migrants (men at least 18 years of age having worked in India for at least 3 months and 
returned to Nepal within three years prior to the date of survey). 
Table 2. Independent variables of Paper II 
Factors  Variables  
Population characteristics  
Predisposing factors Demographics: Age, risk groups and marital status. 
 Social structure: Education, occupation, substance use 
(alcohol and injecting drug use), disclose HIV status to 
anyone except spouse, a close family member and doctor, 
discrimination, violence and housing instability.  
 Beliefs: HIV treatment literacy (measured by 25 true/false 
items) and perceived confidentiality of the medical records 
relating to HIV status in the clinic/hospital PLHIV are visiting. 
Enabling factors Income enrolled in any kind of health insurance program, 
cost to reach ART centre, distance to the ART 
centre, duration of ART started, ART side effects and social 
support (Multidimensional Scale of Perceived Social Support). 
 Need factors Perceived health status, the reason for HIV testing, use of the 
internet to find the HIV-related information, ever diagnosed 
with tuberculosis (TB) after becoming HIV positive (TB/HIV 
co-infection), and HIV/ hepatitis C virus (HCV) co-infection. 
Health system  
Resources/organisation Received home-based care services, relationship with health 
workers (Patient Reactions Assessment (87), health care 
professional ever told other people about HIV status without 
consent, and place of HIV diagnosis (government hospital, 
private hospital, HIV voluntary and counselling centre (VCT) 
in a hospital, VCT centre in non-governmental organization). 
 
For Paper III, the outcome variables were HIV prevalence and unprotected sex (“The last 
time you had sex with your client, did he use a condom?”).  A composite index was created 
based on micro-level physical (client refuse to pay money after having sex), social (poor 
 38 
 
social support and condom negotiation skills) and economic factors (unprotected sex to make 
more money). The index ranges from 0 to 5, where five means sex workers experienced all 
the five adverse conditions. In the analysis, the results based on the logit model were 
converted to the predictive margins and average marginal effects of syndemic conditions on 
unprotected sex. The CI was set at 95%, and the significance level was set at 0.05 in the final 
model. To identify the additive interaction estimate, the relative excess risk due to interaction 
(RERI) for binary exposures was used. A RERI over 0 indicates a synergistic effect of micro-
level social structural factors on unprotected sex. The RERI was 1.97 (95% CI -13.7 to 17.6 ), 
suggesting a positive synergistic effect of micro-level social structural factors on unprotected 
sex.  
 
For Paper IV, changes in HIV prevalence, risk behaviours, socio-demographics and 
comprehensive HIV/AIDS knowledge was assessed. Comprehensive HIV/AIDS knowledge 
was defined as a correct answer to all the following five questions: 1) condoms can be used to 
prevent HIV transmission; 2) HIV can be prevented by limiting sex to one faithful uninfected 
partner; 3) a person can get HIV from mosquito bites; 4) a person can get HIV by sharing a 
meal with someone infected and 5) a healthy-looking person can have HIV. RDS-related data 
were presented and analysed as per the guidelines of the ‘Strengthening the Reporting of 
Observational Studies in Epidemiology for Respondent Driven Sampling Studies’. Moreover, 
information related to RDS seeds, waves, coupons and sample recruitment homophily of the 
survey population was collected. All the RDS-related estimates were adjusted to represent the 
structure of the study population, which is based on information regarding who recruited 
whom, and the relative size of the respondent’s network using the Volz-Heckathorn estimator 
(RDS II). A Chi-square test for trend and for two-stage cluster sampling data, and a 
likelihood ratio test for RDS data, were used to test for trend in proportion. One-way analysis 
of variance or the Kruskal–Wallis test was used to compare changes in mean or median of 
continuous variables. All statistical tests were based on a significance level of a p-value ≤ 
0.05. 
 
3.5 ETHICAL ASPECTS OF THE STUDIES  
 
The protocol for Papers I and II was approved by the responsible research council in each 
country (Bangladesh: Bangladesh Medical Research Council, Number: BMRC/NREC/2010-
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2013/1016; Indonesia: Atmajaya University, Number: 949/III/LPPM-PM.10.01/11/2012; Lao 
PDR: National Ethics Committee for Health Research at the Department of Hygiene and 
Diseases Control, Ministry of Health, Number: 63NECHR; Nepal: Nepal Health Research 
Council, Number: 478; Pakistan: National Institution Bridge Consultants Foundation, 
Karachi; Philippines: Department of Health Research Ethics Committee (DREC), Number: 
DREC201207; Vietnam: Ha Noi School of Public Health, Number: 128/2012/YTCC-HD3. 
MOU was signed between Asia Pacific Network of People Living with HIV (data owner) and 
PhD student to use data for this study. The participation in the CAT-S was voluntary, and 
participants were made aware of the study objectives and study processes at the beginning 
of the interview. Those who were willing to give voluntarily written informed consent 
(thumbprint was obtained from those who were not able to sign) were recruited for the 
CAT-S. Monetary incentives were provided to study participants (5 USD in Lao, Indonesia, 
Nepal and Vietnam and 10 USD in Bangladesh, Pakistan and Philippines) for participation 
in the study. Support was sought from the local law-enforcing agencies to enrol study 
participants from the two Pakistani provinces [Khyber Pakhtoonkhwa bordering with 
Afghanistan (study sites- Peshawar and Swahi) and Baluchistan bordering with Iran and 
Afghanistan (Study sites- Quetta and Turbat)]. 
 
The IBBS survey protocol for Papers III and IV was approved by Nepal Health Research 
Council. Permission was sought to utilise data from National Centre for AIDS and STD 
Control, a government body based in Kathmandu (Ref. no: 069/070/496). The key 
populations who participated in the survey were informed that their involvement in the 
study was entirely voluntary (oral witnessed consent) and that they were free to withdraw at 
any time. They were assured that if they did decide to withdraw, this decision would not 
affect the services that they were offered as part of participation. A consent form regarding 
the nature of the study and confidentiality of their answers was read to them.  
All IBBS survey participants received pre- and post-test counselling on HIV and STIs, a 
physical examination, and treatment for any STI symptoms, as well as vitamins, condoms, 
and transportation reimbursement (2 USD). Key populations who tested HIV-positive were 
informed about the availability of free HIV-related treatment, care, and support services. 
Participants received an incentive of approximately 5 USD (which is around 17% of the 
average weekly income of FSW) for participating in the IBBS survey. 
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3.6 MY ROLE IN THE FIELD WORK, DATA COLLECTION, ANALYSIS AND 
WRITING 
 
I have analysed the raw data from Phase I of the community access to HIV treatment, care 
and support services (CAT-S) implemented in 7 countries. I was directly involved in 
conducting CAT-S Phase II study design workshop and building consensus to finalise 
variables, methods and field implementation plan. I also guided representatives of community 
organisations in their development proposals for ethical approval in each of the seven study 
countries. To achieve the outcomes of the research project, I have worked closely with the 
main officials of Asia Pacific Network of People Living with HIV/AIDS (APN+) based in 
Bangkok and National Centre for AIDS and STD (sexually transmitted disease) Control 
based in Nepal. To be more specific, my role was to contribute to the development of study 
tools, train data collectors, develop data analysis plan, analyse phase I data of CAT-S, 
contribute in draft report writing and sharing it with key stakeholders (for a Paper I, II, III). I 
have also initiated the signing of a memorandum of understanding (MOU) between 
HIV/AIDS group of KI (led by Prof. Anna Mia Ekström) and the Asia Pacific Network of 
People Living with HIV/AIDS with the aim of utilisation of CAT-S data for scientific 
publication.   
Since 2012 I have been directly involved in managing overall IBBS surveys, targeting key 
populations in different epidemic zones in Nepal. My role in relation to the thesis work was 
to finalise the survey tools, provided training to field workers, quality assurance, data 
management, analysis and dissemination of survey findings between 2013 and 2014. I was 
one of the key team members to update the survey tools of Phase II in 2015 to incorporate 
key issues faced by key populations that may have an affect on their behaviours.  
      
 
  
 
  
 41 
 
4 RESULTS 
This section summarises the main findings of Papers I-IV.   
4.1 PREVALENCE OF INCONSISTENT CONDOM USE AND THE 
ASSOCIATED FACTORS AMONG PLHIV (PAPER I) 
Paper I contributes to the understanding of the outcome phase (risk behaviours- inconsistent 
condom use) of the conceptual framework (Figure 4). In Paper I, we found a very high 
prevalence of risk behaviour, measured as inconsistent condom use in the past six months 
among PLHIV with different partners (regular partner 43.3% vs. casual partner 46.2%). 
Inconsistent condom use with various partners varied between countries where PLHIV from 
Lao PDR reported the lowest practice, whereas PLHIV from the Philippines reported the 
highest inconsistent condom use.  
Female participants were more likely to report inconsistent condom use with regular partners 
(marginally significant-adjusted odds ratio (AOR): 1.55; 95% CI: 0.91-2.62, p = 0.088) and 
casual partners (AOR: 1.71; 95% CI: 1.08-2.70, p = 0.029). The likelihood of inconsistent 
condom use was lower among PLHIV living in rural areas (AOR: 0.60; 95% CI: 0.42-0.86, p 
= 0.014) or small towns (AOR: 0.69; 95% CI: 0.53-0.93, p = 0.021), as compared to those 
living in urban areas. FSW were more likely to report inconsistent condom use with regular 
partners (spouse or partner in a relationship with the interviewee for at least three months) 
(AOR: 1.57; 95% CI: 1.21-2.05, p = 0.006). The likelihood of inconsistent condom use with 
regular (AOR: 2.74; 95% CI: 1.70-4.44, p = 0.002) and casual partners (as any other sexual 
partner) (AOR: 5.15; 95% CI: 2.09-12.66, p = 0.003) was higher among refugees than 
PLHIV not belonging to any of these key populations. Being employed (AOR: 0.56; 95% CI: 
0.29-1.04, p = 0.062) and diagnosed with HIV through an HTC centre of a non-governmental 
organization (AOR: 0.63; 95% CI: 0.51-0.77, p = 0.001) lowered the likelihood of 
inconsistent condom use with casual partners. HIV treatment-related literacy (i.e. being aware 
that condoms are still needed even if both sexual partners are HIV-positive) also lowered the 
likelihood of inconsistent condom use with both regular (AOR: 0.52; 95% CI: 0.45-0.62, 
p<0.001) and casual partners (AOR: 0.76; 95% CI: 0.65-0.89, p = 0.006).  
Partner status also significantly affected the likelihood of inconsistent condom use: having a 
partner who was HIV positive (AOR: 3.03; 95% CI: 1.91-4.80, p = 0.001) or not knowing 
partner’s HIV status (AOR: 2.76; 95% CI: 1.69-4.51, p = 0.002) increased the likelihood of 
inconsistent condom use, compared to knowing that the partner was HIV negative.  PLHIV 
who were not on ART or not aware of ART (AOR: 1.40; 95% CI: 1.09-1.81, p = 0.017), who 
experienced physical assault (AOR: 1.57; 95% CI: 1.24-1.99, p = 0.003) or who currently 
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were using  drugs (AOR: 1.90; 95% CI: 1.08-3.36, p = 0.033), had a higher likelihood of 
inconsistent condom use with a causal partner. 
4.2 FACTORS AFFECTING RETENTION IN HIV CARE BETWEEN HIV 
TESTING AND TREATMENT INITIATION (PAPER II) 
Paper II contributes to our understanding of the outcome phase (retention in HIV care) of the 
conceptual framework (Figure 4). Paper II analysed the effects of different factors 
(predisposing, enabling, need and health system) retention in care between HIV testing and 
ART initiation among PLHIV. The study findings suggest that 40% of PLHIV in our study 
presented late for HIV care, with a large variation between countries, from 17% in Pakistan 
to 65% in Lao PDR. Similarly, timely CD4 testing varied from 31% in Nepal to 65% in 
Indonesia. Small variations were observed between countries in other steps of the HIV care 
cascade (engagement in care and ART initiation). Below are the findings related to 
different steps of retention in HIV care.   
HIV testing: PLHIV is presenting with CD4 cell count less than 200 cells/µl at time HIV 
diagnosis.  
Different factors increase the likelihood of presenting late for HIV care such as those who 
identified as transgender, living area (rural and small town), current/past alcohol user and 
public health centre as a place of HIV diagnosis. Details are shown in figure 8 (Figure 8).  
Timely linkage to HIV care: timely appointment with health workers for HIV care and/ or 
having a timely CD4 test performed.  
Factors such as perceived poor health status or not being sure if records are kept 
confidential at the clinic/hospital they were visiting, lowered the likelihood of timely 
appointment with a health worker. Similarly current and past injecting drug use behaviours, 
going overseas for work, and preparation for marriage as a reason for HIV testing, also 
lowered the likelihood of timely CD4 assessment. Details are shown in Figures 8 and 9 
(Figures 8 and 9). 
Engaged in HIV care: PLHIV who had at least one HIV-related medical visit in the last 12 
months.  
Different characteristics such as young age ≤ 24 years, being a prisoner, having no formal 
education, and lacking a health insurance lowered the likelihood of engaging in HIV care. 
Similarly, current injecting drug use behaviour also decreased the likelihood of engaging in 
HIV care but was only marginally significant (Figure 9). 
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ART Initiation: PLHIV eligible for ART who also started ART 
Factors such as good HIV treatment literacy (Condoms are not needed if both sexual 
partners are HIV-positive) and being diagnosed with tuberculosis after HIV infection, 
increased the likelihood of initiating ART. On the contrary, being young (16-24 years) and 
living with HIV, being a FSW and a lack of health insurance significantly lowered the 
chance of initiating ART (Figure 10).  
 
ART adherence: adherence over the past month was assessed by visual analog scale. Visual 
analog scale from 0% to 100% in 10% intervals; 0% meaning that the respondent has not 
taken any medication) and dichotomized into ≤90%: poor vs. >90%: good adherence.     
PLHIV from Bangladesh reported the highest level of adherence to ART (> 95%), while 
participants from the Lao PDR (69.7%) and Vietnam (70%) had the lowest level of 
adherence to ART. Factors such as young age and being a current alcohol user (yes vs. no) 
increased the likelihood of poor ART adherence. On the contrary, a good relationship with 
a health worker (assessed using patient communication index) lowered the likelihood of 
poor ART adherence. The patient communication index (87) assesses the satisfaction level 
of PLHIV regarding the communication they have with their health workers about HIV 
infection and ART treatment (Figure 10). 
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Figure 8. Factors associated with late presentation for HIV care and linkage to care (health workers) among people living with HIV in seven countries of 
the Asia-Pacific region. Coefficients of factors of late presentation for HIV care and linkage to care based on generalized structural equation model 
(GSEM) * p ≤ .05; ** p < .01; *** p < .001; ap= 0.083; b 0.073; cp= 0.084. 
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Figure 9. Factors associated with linkage to care (CD4 test) and engagement in care among people living with HIV in seven countries of the Asia-Pacific 
region.  Coefficients of factors of engagement in care, retention in care and poor ART adherence, based on generalised structural equation model 
(GSEM). * p ≤ .05; ** p < .01; ap= .075.  
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Figure 10. Factors associated with ART initiation and poor ART adherence among people living with HIV in seven countries of the Asia-Pacific region. ¥ 
coefficients of factors of engagement in care, retention in care and poor ART adherence, based on generalized structural equation model (GSEM). * p ≤ 
.05; ** p < .01.
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4.3 PREVALENCE OF HIV AND THE SYNDEMIC EFFECTS OF MICRO-LEVEL 
SOCIAL STRUCTURAL FACTORS OF RISK BEHAVIORS (PAPER III) 
 
Paper III contributes to understanding the synergistic effects of social structural factors on the 
outcome phase (risk behaviors) of the conceptual framework (Figure 4). Paper III also 
assessed the prevalence of HIV among FSW in 22 highway districts of Nepal that share an 
open border with India (Figure 7).   
The HIV prevalence among FSW was 1%. FSW experiencing one adverse syndemic 
condition were 12% more likely to practice unprotected sex with the client than those with no 
condition. The risk of unprotected sex (“The last time you had sex with your client, did he 
use a condom?”- ‘yes vs. no’) increased with experience of additional adverse conditions (for 
example poor social support, poor condom negotiation skills). Details are shown in Table 5 
(Table 5).  
 Table 5. Average marginal effects of syndemic conditions on unprotected sex among 
female sex workers in Nepal, 2012. 
 
Syndemic 
conditions 
 
Average marginal effects on 
unprotected sex  
 
95% confidence interval 
 
p-value 
 
1 
 
.12 
 
.04 
 
.21 
 
0.005 
2 .19 .09 .29 0.000 
3 and above .38 .25 .52 0.000 
Other covariates included in logit model- age, education, income, place of solicitation, the length of 
time working as a sex worker and days per week working as a sex worker.  
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4.4 TRENDS IN HIV PREVALENCE AND RISK BEHAVIORS AMONG YOUNG 
KEY POPULATIONS IN NEPAL (PAPER IV) 
 
Paper IV contributes to understanding the synergistic effects of social structural factors on the 
outcome (risk behaviours) and impact (HIV prevalence) phase of the conceptual framework 
(Figure 4). Paper IV analysed the trends in HIV prevalence, risk behaviors (non-use of 
condoms, needle/syringe sharing) and other individual-level factors related to 
sociodemographics, comprehensive HIV/AIDS knowledge and other risk factors among 
young key populations aged 16-24 years (PWID, MSM/TG, FSW and male labour 
migrants) over a 12 year period (2001-2012 in Nepal). To better characterise the epidemic, 
we analysed trends in HIV prevalence and risk behaviours by local epidemic zones (Figure 
7). The HIV epidemic zones in Nepal are the Valley (capital city-Kathmandu Valley, major 
tourist area-Pokhara Valley), the Hills (West to Farwest) and the Terai Highway (districts 
which share an open border with India). The burden of HIV in not consistent throughout the 
country, so the local HIV epidemic zones have been identified in Nepal based on the size 
and distribution of key population at risk, mobility links and HIVrelated risk behaviours. 
Paper IV found a sharp decline in HIV prevalence and risk behaviours among young key 
populations (PWID and MSM/TG) in the different epidemic zones of Nepal (Figure 11 and 
Table 6). Similarly, the decline in HIV prevalence was also consistent with improved 
condom use among young FSW (Table 6). Though the prevalence of HIV was low 
throughout the study period among young labour migrants, the changes in condom use 
behaviour with sex workers are not consistent (use of condoms increased with Indian FSW 
but declined over time among Nepalese FSW). Also, changes over time in other risk factors 
(age of the first injection, place of solicitation, injection frequency) were not consistent 
between epidemic zones in Nepal. 
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Figure 11. Trends in HIV prevalence, risk behaviours and comprehensive HIV/AIDS knowledge among young people who inject drugs aged 16–24 
years, by epidemic zones and year of survey, Nepal 2003–2012 (N=2767). p values in the East and West-to-Far West Terai highway were calculated 
after excluding 2003 and 2005 survey data.
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Table 6. HIV prevalence, risk behaviors and comprehensive HIV/AIDS knowledge among 
young MSM/TG in Kathmandu valley and male labour migrants aged 16-24 years in West-
To-Farwest hills, by year of survey, Nepal 2004-2012 (N= 1887)  
Characteristic % (95% CI) % (95% CI) % (95% CI) % (95% CI) p-
trend 
MSM/TG 2004 2007 2009 2012  
Comprehensive 
HIV/AIDS Knowledge 
35 (23-48) 52  (37-67) 47 (32-61) 53 (35-71) 0.084 
Condom use among 
MSM/TG in last anal sex 
with male sex partner 
 
- 
72.1 (62-82) 66.8 (52-81) 80.1 (77-84) 0.098 
Condom use among 
MSM/TG with non-
paying male partner at 
last anal sex 
71.4 (60-
83) 
71.5 (62-81) 71.1 (56-86) 84.9 (60-99) 0.361 
Condom use among 
MSW* with casual male 
client at last anal sex 
82.6 (55-
99) 
98.7 (86-99) 97.3 (95-97) 86.6 (76-97) 0.225 
Condom use among 
MSW* with regular 
male client at last anal 
sex  
77 (40-99) 93 (81-99) 82 (67-98) 97 (95-99) 0.150 
HIV prevalence 5.9 (3-9) 4.3 (0.01-10.6) 0.2 (0.002-
0.5) 
0.7 (0.6-0.8) 0.005 
Male labour migrants  2001 2006 2008 2012  
Comprehensive 
HIV/AIDS Knowledge 
- 0.6 (0.002-1.4) 19 (14-23) 11 (7-15) <0.01 
Had sex with FSW in 
Nepal† 
- 3 (1-5) 2 (0.03-3.0) 10 (6-13) <0.01 
Condom use at last sex 
with FSW in Nepal 
- 40 (10-70) 75 (33-99) 56 (37-76) 0.001 
Had sex with FSWs in 
India† 
- 7 (3.9-9.3) 5 (8.1-15.9) 10 (6-13) 0.103 
Condom use at last sex 
with FSW in India 
- 73 (54-91) 83 (62-99) 84 (69-98) 0.059 
HIV prevalence (%) 0.0 0.6 0.0 0.4 - 
† In the last 12 months; CI, Confidence interval; MSM/TG, Men who have sex with men/ Transgender; MSW*, 
Male sex workers. 
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5 DISCUSSION  
The findings of this thesis demonstrate that the following issues act as a threat to achieving 
positive results in the spectrum from input (interventions) to impact (declining HIV 
prevalence as well as AIDS-related deaths among key populations and PLHIV in the study 
countries) (Figure 4). A high prevalence of unprotected sex and a high proportion presenting 
late for HIV care delaying linkage to ART, was widely prevalent among PLHIV in seven 
study countries. The experience of adverse conditions (poor social support, economic 
vulnerability) increased the odds of unprotected sex among FSW. Although HIV prevalence 
and risk behaviours are declining over time among young key populations, those who had 
become HIV-positive were not so likely to engage in HIV care or had poor ART adherence. 
The results from this thesis demonstrate that four out of every 10 PLHIV in the seven studied 
countries practise unsafe sexual behaviours with different partners (regular and casual 
partners) (Paper I). The prevalence of these unsafe sexual behaviours among PLHIV with 
casual partners differs widely between study countries, i.e. from 16% in Lao PDR to 60% in 
the Philippines.  A 40% of PLHIV presented late for HIV care (CD4 count of <200 cells/uL) 
but delayed linkage to care varied greatly between the study countries (6% in Lao PDR to 
46% in Vietnam) (Paper II).  
Almost a quarter of the studied FSW had unprotected sex with their clients in the 22 Terai 
highway districts of Nepal that share an open border with India, but the HIV prevalence was 
still low in comparison to FSW in other Asian countries (Paper III). Analyses of surveillance 
survey data from the last 12 years (2001-2012) suggest that the decline in HIV prevalence is 
paralleled by a reduction in risk behaviours among young key populations aged 16-24 years 
in Nepal. In Nepal, the decline in HIV prevalence over the past decade was remarkably 
significant and consistent with an increase in condom use and safer use of clean needles 
and syringes.  
 Condom use behaviour among PLHIV (Paper I) 
Paper I found that women and key populations (MSM, PWID and FSW) were more likely to 
practice inconsistent condom use behaviours with different partners in line with previous 
studies (9, 88). Various factors such as poverty and rooted gender inequities in the region 
increase the risk of survival sex and low self-esteem, including poor condom negotiation 
skills among FSW (89-91). An unsafe working environment (unavailability of condoms, 
policing policies) also influences condom use behaviours among sex workers in the region 
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(32). Many countries in the region also lack plans and efforts to address unsafe sex among 
refugee and internally displaced persons (92-94).    
We found that the experience of physical assault among PLHIV was associated with 
inconsistent condom use, which is consistent with other published studies (95, 96). The 
experience of physical assault increases sexual risk-taking behaviours (inconsistent condom 
use) through different pathways such as forced sex with a perpetrator and reduced capacity to 
negotiate condom use (97). A poor HIV treatment literacy (not knowing that condoms are 
still needed if both partners are HIV positive), having a regular partner whose HIV status was 
either positive or unknown, and not being on ART (the overall ART coverage was 24% but 
varied from 3% in Lao PDR to 33-34% in Nepal and Philippines) also increased inconsistent 
condom use among PLHIV. This indicates that the benefits of treatment as prevention is 
limited in study countries. 
Retention in HIV care between HIV testing and ART initiation (Paper II)  
We found different barriers and facilitators associated with various steps of the HIV care 
continuum associated with predisposing (young age, no formal education, sex work, 
transgender identity, prisoners, transgender identity, alcohol/injecting drug use, HIV 
treatment literacy), enabling (enrolled in health insurance program), need (perceived poor 
health status, self-referral for HIV testing, referral from a health worker and diagnosis of 
tuberculosis/HIV co-infection) and health system (good client-provider communication, fear 
of confidentiality breach, public hospital as the place of HIV diagnosis) factors. 
Previous research has found that PLHIV belonging to key populations (PWID, TG, FSW and 
prisoners) are less likely to remain in HIV care because of criminalization of their behaviours, 
because of unsafe work environments for sex workers, and, because of discrimination based 
on sexual orientation (98-101). Unavailability or intermittent delivery of poor quality HIV 
services in prison and the brief nature of prisoners (102) often results in poor ART access, 
adherence and retention in HIV care among prisoners. Those PLHIV who were not sure 
whether their medical records were kept confidentially in the health centres, delayed uptake 
of ART and linkage to HIV care (meeting health workers within 30 days of HIV diagnosis) 
(Paper II). Confidentiality breach by health workers is widely prevalent in many countries in 
the region despite the availability of guidelines the protection of privacy of PLHIV (103-
105). PLHIV satisfied with the information provided by the health workers about the illness 
were more likely to adhere to treatment (Paper II), which is consistent with previous studies 
(106, 107).  
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PLHIV enrolled in a health insurance program were more likely to engage in care and initiate 
ART (Paper II). Social protection with different names (Vietnamese Social Security Social 
Health Insurance Program etc.)  targeting PLHIV —which provides CD4 cell count tests free 
of charge, monthly cash allowance for daily necessities and common drug provision— are 
implemented in four study countries (Indonesia, Vietnam, Philippines and Lao PDR). 
However, the coverage and awareness among PLHIV of such social protection programs is 
limited in those countries (18-20). Despite the implementation of different social protection 
programs, PLHIV living in Indonesia, Lao PDR and Vietnam often experience a catastrophic 
financial burden while seeking various HIV-related services, such as viral load tests, hospital 
admission fees or diagnosis and treatment of comorbid diseases (6, 17, 18). Although PLHIV 
receive free HIV treatment (ART) from the public system, insurance that covers general 
health care costs among PLHIV does not exist neither in Bangladesh nor in Nepal. PLHIV in 
Pakistan can enrol in a health insurance program, but information on the coverage and 
effectiveness of this program in reducing the financial burden related to HIV services is not 
available. 
 Synergistic effects of micro-level structural factors and HIV risk (Paper III) 
The prevalence of HIV among FSW in Nepal was lower than among sex workers in other 
countries (HIV prevalence in India 13.7% and Thailand 11.9%) (16). Available interventions 
may contribute to a lower HIV prevalence among FSW in Nepal. The micro-level social 
structural factors related to physical (experience of undesirable events), social (poor social 
support and condom negotiation skills), and economic (unprotected sex to make more 
money) act in a dose-response relationship to increase unprotected sex among Nepalese sex 
workers (Paper III). Other studies in the Philippines, USA, and Vietnam have also found that 
physical, social and economic level factors interact and are associated with unprotected sex 
among FSW (42, 108, 109).     
 
Trends in HIV prevalence and risk behaviours among young key populations (Paper IV) 
Young key populations in Nepal are experiencing declining trends of HIV prevalence and 
risk behaviours in different epidemic zones (Paper IV). However, other countries in the 
region (Cambodia, Pakistan and Thailand) are experiencing different scenarios, such as 
higher levels of risk behaviours and increased HIV incidence and prevalence (25, 110-112). 
Similarly, the practice of multiple risk behaviours among young key populations (e.g. 
MSM/TG sometimes both use drugs and also sell sex, and drug users also sell sex) is widely 
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prevalent in Cambodia, Pakistan and Thailand (25, 111, 114) but less so in Nepal (113). The 
aforementioned differences in the burden of HIV in Nepal compared to other nations in the 
region may be attributed to several factors including an improved social capital and high 
coverage of interventions early on already since the inception of the epidemic. A favourable 
policy environment to protect the health and rights of key populations also exists in Nepal 
(13, 37). However, much preventive work remains to be done, for example the change in 
other risk determinants (mean age at first injection, injection frequency, solicitation place) is 
not consistent between epidemic zones overtime in Nepal.   
 
 
5.1 METHODOLOGICAL CONSIDERATIONS  
 
Paper I and Paper II 
In Papers I and II, a community-based participatory research (CBPR) approach (84), called 
CAT-S (community access to HIV treatment care and support services study) was used to 
design, implement and use of research findings. CBPR promotes the collaboration between 
researchers, community and organisations to identify the problem of interest and propose 
its solutions. Participation from the community was highly prioritised in the different 
phases of the research (prioritising the problem/research question, planning/implementing 
the field activities, analysing collected data and disseminating the results for advocacy and 
proper response) to enhance the ownership of the process. The Agency for Healthcare 
Research and Quality define CBPR as: “Community-based participatory research is a 
collaborative research approach that is designed to ensure and establish structures for 
participation by communities affected by the issue being studied, representatives of 
organizations, and researchers in all aspects of the research process to improve health and 
well-being through taking action, including social change.”(115) 
CAT-S is a collaborative effort of community members, organisational representatives (Asia-
Pacific Network of People Living with HIV/AIDS) and researchers (85). PLHIV from the 
seven study countries actively participated in different phases of the research such as the 
planning phase (formulation of priority such as treatment access, identification of study sites 
and preparation of documents for ethical approval), the field work phase (recruitment and 
training of the field researchers, implementation of field work), and the action phase 
(development of effective advocacy messages based on study findings and dissemination of 
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findings at national level). The use of CBPR has both advantages and disadvantages. One 
lesson learnt after the implementation of CBPR was that PLHIV are not only the target 
population of the research but could and should also manage the research and contribute to 
generating evidence and prioritisation of response activities. Their experiences of day-to-day 
life e.g. challenges in terms of accessing treatment, also helped us to refine the study 
variables. Their involvement in the study also contributed to recruiting hidden and 
marginalised PLHIV who were experiencing the double burden of their HIV status and 
belonging to a key population (MSM, TG, and/or sex workers). However, the major 
limitation of using CBPR was that the use of evidence for advocacy and response 
prioritization was not uniform across the study countries. The overall process in terms of 
utilising our study findings may affect the interest and capacity among community leaders 
regarding understanding the bigger picture and in terms of implementing research results. 
Some other limitations also exist in the findings of Papers I and II due to the design and the 
methodology used for data collection. An assessment of retention in HIV care over time was 
not feasible due to the analysis of baseline data. Paper II gives the proportion of PLHIV who 
initiated ART and factors associated with this. However, considering that PLHIV ae 
supposed to stay on ART for life, information on the proportion of PLHIV who initiate ART 
but and who also remain on treatment over time it is very important to assess treatment 
effectiveness since some stop treatment or drop out of care. In addition, some outcomes of 
interest such as ART initiation could have been overestimated, if the characteristics of the 
study participants differed from those who did not participate or refused to take part in the 
study. For example, study participants may more aware of available treatment options and 
more likely to initiate ART than other PLHIV because of their association with a national 
network of PLHIV. If so, the real problems are even bigger than what we have estimated. 
The collection of information about sensitive issues (sexual behaviour, sexual orientation, sex 
work) as well as the retrospective nature of interviewing, may result in social desirability bias 
and recall bias. PLHIV may tend to report socially acceptable responses, so-called ‘good 
norms or behaviours’, such as the use of condoms and not having sex with multiple partners 
etc. The effect of such bias may result in underestimation of non-use of condoms with 
different partners. Some study variables that require recalling information from the past, such 
as CD4 level at the first HIV diagnosis, may be reported less accurately by PLHIV who were 
diagnosed with HIV a long time back. Different strategies were used to reduce the effects of 
the various biases mentioned above, such as informing study participants of the importance of 
responding accurately and their responses would be treated confidentially. .   
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 Papers III and IV 
We have analysed secondary data from surveillance surveys to answer the research questions 
of Papers III and IV. The disadvantage of secondary data is the unavailability of all the 
required variables in a usable format. For example, in Paper III there were no variables 
related to structural factors that operate at macro level limiting data analysis.  
The sampling techniques (two-stage cluster sampling and RDS) used to enrol study 
participants may also have influenced the estimate of the outcome of interest. The mapping 
phase to develop the sampling frame in two-stage cluster sampling is influenced by the 
information provided by community people or local organisations. If the characteristic of sex 
workers who were not recorded or who were missed during the mapping phase is different 
from those who were intervewied, then that might cause a selection bias which results in 
either an under -or an overestimation of the outcome of interest. Another scenario is if the 
particular cluster is missed during the listing of clusters,. Then there is a risk that FSW who 
work in missed clusters (for example FSW operating from rented apartments) have different 
characteristics with regards to the outcome of interest than those FSW who work in other 
clusters (for example dance bars, massage parlours). The collection of sensitive information 
through face to face interviews may also result in social desirability bias. However, 
considering that a significant proportion of key populations in Nepal have no formal 
education, a self-administered questionnaire was not viable.   
RDS is widely used to enrol hidden and marginalised populations such MSM/TG and PWID. 
It is assumed that use of RDS produces unbiased estimates if its key assumptions are met. 
However, in some cases, RDS could have reached only one subset of the study population 
e.g. if there is no cross-referal between young and old or between different ethnic groups. 
Various strategies  to minimise recruitment bias were used in the RDS surveys among key 
populations in Nepal for example making sure that seed characteristics were diverse and also 
consistent with baseline surveys.   
 The results of a trend analysis are influenced by several factors such as the natural course of 
an HIV epidemic, social desirability bias over time, sampling technique and HIV testing 
strategy.  At the start of an HIV epidemic, individuals with high-risk behaviours are more 
likely to become infected rapidly, and new infections dwarf mortality due to the chronic 
nature of HIV and the slow progression rate from HIV to AIDS.  As the epidemic progresses, 
HIV incidence declines due to lower risk behaviours among remaining at risk individuals, 
even despite a lack of preventive interventions. However, such effects is unlikely to affect the 
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results in Paper IV because the young people who particpated during this study period were 
from different birth cohorts compared to those young people infected in the early years of the 
epidemic. This phenomenon has also been pointed out by The International group on analysis 
of trends in HIV prevalence and behaviours in young people (116). 
The effects of social desirability bias in IBBS surveys was minimised by the non-collection 
of personal identifiers, and all interviews were anonymous. The collection of both biological 
and behavioural information through different methods (rapid tests and face to face 
interviews) also reduced any effects of social desirability bias. The results of biological 
samples were confirmed through external quality assurance after completion of data 
collection in the IBBS surveys (Papers III and IV).  
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6   CONCLUSIONS  
 
• Non-use of condoms with different (regular and casual) partners was highly prevalent 
among PLHIV in the seven study countries (Paper I). Inconsistent condom use with 
different partners among PLHIV was associated with previous experience of physical 
abuse, poor HIV treatment literacy and not being enrolled on ART (Paper I). In addition 
to FSW and drug users, refugees were also more likely to report inconsistent condom 
use with regular and casual partners (Paper I). 
• A high proportion of PLHIV presented late for HIV care (CD4 cell less than 200/µl). 
Moreover, delayed linkage to care (not having one or more documented CD4 tests within 
three months of an HIV diagnosis) was common among PLHIV. However, engagement 
in HIV care, ART initiation and adherence to ART was at an acceptable level (more than 
or equal to 80%) (Paper II).   
•  PLHIV with good HIV treatment literacy were more likely to initiate ART. Health 
system factors such as good client-provider communication related to HIV treatment 
enhances adherence to HIV  treatment. Young PLHIV (16-24 years) were less likely to 
engage in HIV care, not start ART and also had poor adherence to ART. Similarly, 
prisoners were less likely to engage in HIV care. PLHIV not enrolled in any health 
insurance program were less likely to engage in care and not initiate ART (Paper II).     
• Micro-level social structural factors related to physical (experience of undesirable 
events), social (poor social support and condom negotiation skills) and economic 
(unprotected sex to make more money) levels act synergistically to increase the 
likelihood of unprotected sex among female sex workers in Nepal (Paper III).  
• HIV prevalence and risk behaviours are declining or have stabilised at a low level (≤3%) 
among young key populations (PWID, MSM/TG, FSW and male labour migrants) in 
Nepal. However, changes in other risk determinants such as mean age at starting first 
injection, injection frequency, place of commercial sex solicitation, mean age when 
leaving for work abroad, were not consistent between epidemic zones in Nepal (Paper 
IV).   
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7 PROGRAMMATIC AND POLICY IMPLICATIONS  
 
• Enhance the treatment as prevention benefits of ART. HIV programs should prioritise 
early detection of HIV and to enrol PLHIV who are not on ART on treatment as soon a 
possible, as well as making PLHIV aware of the health and prevention benefits of ART.   
• Target missed key populatiosn such as refugees and prisoners with prevention and 
treatment services. Currently, the national plans of most of the countries in the region 
lack clear strategies to address inconsistent condom use among refugees., Also many 
countries in the region lack HIV services in prison menaing that ART often is interrupted 
when PLHIV belonging to key populations (PWID, FSW) are incarcerated. Implementing 
HIV programmes into the prison setting is crucial to ensure that ART is delivered 
uninterrupted during incarceration to prevent illness, secondary HIV transmission and 
ARV drug resistance.   
• Design and implement interventions to address the gap of timely identification of PLHIV 
and linking them to HIV care. Paper II clearly suggests that the biggest problem lies in the 
late presentation of PLHIV for HIV care. Proper implementation of the ‘test and treat’ 
strategy would help to address the issue of delayed linkage of PLHIV in HIV care. 
• Design and implement sustainable social protection programs. Paper II demonstrates that 
PLHIV without health insurance were less likely to engage in care and to not initiate 
ART. Efforts should be made to more easily enrol PLHIV in such protection programme, 
and  to improve the coverage of health insurance for PLHIV.     
• HIV prevention programme should incorporate strategies to address the negative effects 
of social structural factors. Existing behavioural interventions lack elements to address 
the social structural factors that increase the likelihood of unprotected sex. Future efforts 
should include strategies to address negative micro level social structural factors (for 
example poor social support, poor condom negotiation skills, economic vulnerability)  to 
make behavioural interventions more effective. Only distributing condoms will not stop 
risky behaviours among sex workers. 
• Prioritise young PLHIV-friendly HIV care services. The current blanket approach does 
not adequately address the specific treatment needs and demands of young PLHIV. Thus, 
needs assessments among young PLHIV should be prioritised to improve their retention 
in HIV care.      
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